Skip to main content
Figure 4 | BMC Neuroscience

Figure 4

From: Enhanced cerebrovascular expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 via the MEK/ERK pathway during cerebral ischemia in the rat

Figure 4

Immunoblots showing MMP-9 and TIMP-1 protein expression levels in the middle cerebral artery 48 hours after MCAO using β-actin as a loading control. Treatment with U0126 at 0 hours post occlusion decreased the MCAO-induced enhanced expression of MMP-9 and TIMP-1 receptor proteins. Data from four experiments (each performed on vessels from 3 rats) are expressed as mean ± SEM, n = 4. *P < 0.05, **P < 0.01.

Back to article page